Vivos Therapeutics
VVOS
VVOS
28 hedge funds and large institutions have $861K invested in Vivos Therapeutics in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$16K | |
| 2 | +$10.2K | |
| 3 | +$4K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.78K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$38 |
Top Sellers
| 1 | -$47.4K | |
| 2 | -$32.3K | |
| 3 | -$26K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$19K |
| 5 |
Renaissance Technologies
New York
|
-$17K |